Capital International Investors
NVAX icon

Capital International Investors’s Novavax NVAX Stock Holding History

Capital International Investors’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-235,000
Closed -$33.6M – 473
2021
Q4 		$33.6M Hold
235,000
– – 0.01% 380
2021
Q3 		$48.7M Hold
235,000
– – 0.01% 351
2021
Q2 		$49.9M Hold
235,000
– – 0.01% 356
2021
Q1 		$42.6M Buy
+235,000
New +$46.8M 0.01% 349

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Capital International Investors's NVAX Position: Q1 2022 in Review

Capital International Investors sold out of Novavax (NVAX) in Q1 2022, closing a stake of 235,000 shares — an estimated $33.6M sold.

Capital International Investors first reported a position in NVAX in Q1 2021 and held it in 4 quarters. The position peaked at $49.9M in Q2 2021. 382 funds tracked by Wall St. Rank hold NVAX as of Q1 2022.

  • Capital International Investors reported no remaining Novavax position as of Q1 2022 after selling out during the quarter.
  • Capital International Investors sold 235,000 Novavax shares in Q1 2022, an estimated $33.6M.
  • Capital International Investors first reported a position in Novavax in Q1 2021 and held it in 4 quarters.
  • Capital International Investors's Novavax position peaked at $49.9M in Q2 2021.
  • 382 funds tracked by Wall St. Rank held Novavax as of Q1 2022.

Based on Capital International Investors's 13F filing for Q1 2022, filed 16 May 2022.